Daxor Corporation Appoints Richard Prall as National Sales Manager.

Business Editors/Health & Medical Writers

NEW YORK--(BUSINESS WIRE)--Sept. 9, 2002

Initiating Major Expansion Commitment to Sales and

Marketing Department

Daxor, Inc. (Amex: DXR), the developer and manufacturer of the BVA-100 Blood Volume Analyzer, today announced that Richard Prall has been named Vice President and National Sales Manager.

Mr. Prall brings more than 19 years of healthcare/medical device product sales and marketing experience to DXR. Prall most recently served as Eastern Sales Manager for Toshiba America Medical Systems. At Toshiba, he was responsible for all diagnostic imaging equipment accounts and managed 5 area managers, as well as 37 sales representatives. Prior to Toshiba, Prall was Northeast Regional Sales Manager for Acuson Corporation from 1997 to 1999, a market leader in Ultrasound equipment. At Acuson, he was responsible for increasing the cardiac market share, through the introduction of a new product line. Prior to Toshiba and Acuson, from 1995 to 1997, Prall was Vice President of Sales and Marketing at Sodexho, USA expanding their sales and marketing division. From 1990-1995, he was Regional Sales Manager for GE Medical Systems where he led a sales team of 17 professionals. He also worked at Vistakon Inc. a division of Johnson and Johnson as Northwest District Sales Manager from 1988 to 1990 and at Bristol Myers from 1983 to1988 as Northeast Regional Sales Manager.

Joseph Feldschuh, MD, President and CEO of Daxor, said, "We are very pleased that Richard Prall has joined Daxor to head our national sales effort. This is an exciting time for Daxor, as we are now ready to follow through on the sales strategy of our business plan and reward the patience of our shareholders. We expect this to be the first but not the last highly experienced sales professional to join the Daxor team this year as we initiate our business plan to increase our sales significantly.

Richard's impressive experience at major healthcare companies and broad expertise in healthcare/medical device products will be of great benefit to Daxor. He has highly developed leadership skills and an outstanding record in sales from leading healthcare/medical device companies. His experience in managing sales managers and representatives will be instrumental in building our sales department and Daxor's revenue. In addition, he understands the important role Daxor can play in improving health outcomes and reducing health care costs. We are extremely pleased to have Rick join our management team."

About Daxor Corporation

Daxor manufactures and markets the BVA-100 a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with a single use diagnostic kit. It is the first instrument to provide rapid direct measurement of a patient's blood volume. The BVA-100 enables physicians to have access to technology which allows them to obtain blood volume measurements rapidly and with a high degree of precision.

The Cleveland Clinic, Johns Hopkins Medical Center, the Mayo Clinic, Vanderbilt Medical Center, Columbia Presbyterian Medical Center and the Methodist Hospital in San Antonio Texas are utilizing the BVA-100 Blood Volume Analyzer.

Additional information about the BVA-100 and other medical studies can be found on Daxor's website at www.daxor.com.

Certain statements contained in this news release may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, the U.S. Securities act of 1933, and the U.S. Securities Exchange Act of 1934. To the extent that any of the statements contained herein are forward-looking, such statements are based on current expectations and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward looking statements. We caution investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors, including, but not limited to, economic conditions and developments within the industry; competition and pricing pressures; length of the sales cycle and management continuity.